CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-10 | Parsey Merdad Chief Medical Officer | Option exercise | +3,820 | 84,621 | ||
| 2024-12-10 | Parsey Merdad Chief Medical Officer | Shares withheld for taxes | −1,771 | $92.34 | $164K | 82,850 |
| 2024-12-10 | Parsey Merdad Chief Medical Officer | Option exercise · Restricted Stock Unit | −3,820 | 36,753 | ||
| 2024-12-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +10,295 | 506,290 | ||
| 2024-12-10 | O'Day Daniel Patrick Chairman & CEO | Shares withheld for taxes | −4,762 | $92.34 | $440K | 501,528 |
| 2024-12-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −10,295 | 104,977 | ||
| 2024-12-10 | Mercier Johanna Chief Commercial Officer | Option exercise | +3,752 | 76,879 | ||
| 2024-12-10 | Mercier Johanna Chief Commercial Officer | Shares withheld for taxes | −1,739 | $92.34 | $161K | 75,140 |
| 2024-12-10 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −3,752 | 36,193 | ||
| 2024-12-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +3,640 | 142,559 | ||
| 2024-12-10 | Dickinson Andrew D Chief Financial Officer | Shares withheld for taxes | −1,686 | $92.34 | $156K | 140,873 |
| 2024-12-10 | Dickinson Andrew D Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,640 | 35,487 | ||
| 2024-11-29 | Dickinson Andrew D Chief Financial Officer | Option exercise 10b5-1 | +18,630 | $73.77 | $1.4M | 157,549 |
| 2024-11-29 | Dickinson Andrew D Chief Financial Officer | Option exercise 10b5-1 | +26,170 | $57.92 | $1.5M | 183,719 |
| 2024-11-29 | Dickinson Andrew D Chief Financial Officer | Option exercise 10b5-1 | +33,660 | $68.75 | $2.3M | 217,379 |
| 2024-11-29 | Dickinson Andrew D Chief Financial Officer | Option exercise 10b5-1 | +60,885 | $71.91 | $4.4M | 278,264 |
| 2024-11-29 | Dickinson Andrew D Chief Financial Officer | Option exercise 10b5-1 | +43,340 | $72.70 | $3.2M | 321,604 |
| 2024-11-29 | Dickinson Andrew D Chief Financial Officer | Option exercise 10b5-1 | +65,960 | $72.70 | $4.8M | 387,564 |
| 2024-11-29 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −120,715 | $92.77 | $11.2M | 266,849 |
| 2024-11-29 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −127,930 | $92.76 | $11.9M | 138,919 |
Page 22 of 30 · 599 trades